相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
Andreas Hallqvist et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer
Remco J. Molenaar et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
Mark Tulchinsky et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an inconvenient truth?
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes
Miriam Rottmann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors
Stig Palm et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Absorbed Doses and Risk Estimates of 211At-MX35 F(ab′)2 in Intraperitoneal Therapy of Ovarian Cancer Patients
Elin Cederkrantz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
The potential and hurdles of targeted alpha therapy - clinical trials and beyond
Jorgen Eigqvist et al.
FRONTIERS IN ONCOLOGY (2014)
Associations between first and second primary cancers: a population-based study
Sune F. Nielsen et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
US ENVIRONMENTAL PROTECTION AGENCY RADIOGENIC RISK MODELS AND PROJECTIONS FOR THE US POPULATION
David J. Pawel et al.
HEALTH PHYSICS (2012)
Incidence of Malignant Diseases in Humans Injected with Radium-224
Elke Anna Nekolla et al.
RADIATION RESEARCH (2010)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Incidence of leukaemia and other malignant diseases following injections of the short-lived α-emitter 224Ra into man
Roland R. Wick et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2009)
Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study
Nikolaus Becker et al.
EUROPEAN JOURNAL OF CANCER (2008)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast
LB Travis et al.
RADIATION RESEARCH (2003)
Peteosthor - a medical disaster due to Radium-224 - A personal recollection
H Spiess
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2002)
Therapy of ankylosing spondylitis with 224Ra-radium chloride:: dosimetry and risk considerations
M Lassmann et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2002)
分享论文
